Boc-His(Bom)-OHCAS# 79950-65-5 |
2D Structure
- Cisplatin
Catalog No.:BCN1552
CAS No.:14283-03-5
- Z-VAD-FMK
Catalog No.:BCC1126
CAS No.:187389-52-2
- Z-WEHD-FMK
Catalog No.:BCC1139
CAS No.:210345-00-9
- Z-LEHD-FMK
Catalog No.:BCC5117
CAS No.:210345-04-3
- AZ 10417808
Catalog No.:BCC2356
CAS No.:331645-84-2
- Apoptosis Activator 2
Catalog No.:BCC2099
CAS No.:79183-19-0
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 79950-65-5 | SDF | Download SDF |
PubChem ID | 7023105 | Appearance | Powder |
Formula | C19H25N3O5 | M.Wt | 375.4 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-[3-(phenylmethoxymethyl)imidazol-4-yl]propanoic acid | ||
SMILES | CC(C)(C)OC(=O)NC(CC1=CN=CN1COCC2=CC=CC=C2)C(=O)O | ||
Standard InChIKey | LPVKZCHCZSFTOJ-INIZCTEOSA-N | ||
Standard InChI | InChI=1S/C19H25N3O5/c1-19(2,3)27-18(25)21-16(17(23)24)9-15-10-20-12-22(15)13-26-11-14-7-5-4-6-8-14/h4-8,10,12,16H,9,11,13H2,1-3H3,(H,21,25)(H,23,24)/t16-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Boc-His(Bom)-OH Dilution Calculator
Boc-His(Bom)-OH Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.6638 mL | 13.3191 mL | 26.6383 mL | 53.2765 mL | 66.5956 mL |
5 mM | 0.5328 mL | 2.6638 mL | 5.3277 mL | 10.6553 mL | 13.3191 mL |
10 mM | 0.2664 mL | 1.3319 mL | 2.6638 mL | 5.3277 mL | 6.6596 mL |
50 mM | 0.0533 mL | 0.2664 mL | 0.5328 mL | 1.0655 mL | 1.3319 mL |
100 mM | 0.0266 mL | 0.1332 mL | 0.2664 mL | 0.5328 mL | 0.666 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Boc-His(Bom)-OH
- Idazoxan hydrochloride
Catalog No.:BCC6798
CAS No.:79944-56-2
- ML130 (Nodinitib-1)
Catalog No.:BCC4611
CAS No.:799264-47-4
- Forsythoside A
Catalog No.:BCN1195
CAS No.:79916-77-1
- Simvastatin
Catalog No.:BCN2569
CAS No.:79902-63-9
- 1,2,3,6-Tetragalloylglucose
Catalog No.:BCN2159
CAS No.:79886-50-3
- Castanospermine
Catalog No.:BCC6783
CAS No.:79831-76-8
- Loratadine
Catalog No.:BCC1262
CAS No.:79794-75-5
- H-Hyp(tBu)-OH
Catalog No.:BCC3249
CAS No.:79775-07-8
- Levonorgestrel
Catalog No.:BCC4792
CAS No.:797-63-7
- Linifanib (ABT-869)
Catalog No.:BCC1261
CAS No.:796967-16-3
- Crassicauline A
Catalog No.:BCN2516
CAS No.:79592-91-9
- Alarelin Acetate
Catalog No.:BCC1336
CAS No.:79561-22-1
- Quinovic acid 3-O-beta-D-glucoside
Catalog No.:BCN4334
CAS No.:79955-41-2
- Fmoc-D-Ala-OH
Catalog No.:BCC3036
CAS No.:79990-15-1
- Blumeatin B
Catalog No.:BCN4335
CAS No.:79995-67-8
- Dapsone
Catalog No.:BCC5220
CAS No.:80-08-0
- Sulfamethoxypyridazine
Catalog No.:BCC4728
CAS No.:80-35-3
- Homatropine Methylbromide
Catalog No.:BCC4571
CAS No.:80-49-9
- Alpha-pinene
Catalog No.:BCN3855
CAS No.:80-56-8
- Tiglicacid
Catalog No.:BCN2976
CAS No.:80-59-1
- Sulfisoxazole Acetyl
Catalog No.:BCC5630
CAS No.:80-74-0
- Dihydrocholesterol
Catalog No.:BCN2749
CAS No.:80-97-7
- Soybean phospholipid
Catalog No.:BCN3888
CAS No.:8002-43-5
- Agatharesinol acetonide
Catalog No.:BCN4574
CAS No.:800389-33-7
Synthesis of the novel pi-(benzyloxymethyl)-protected histidine analogue of statine. Inhibition of penicillopepsin by pepstatin-derived peptides containing different statine side-chain derivatives.[Pubmed:2661819]
J Med Chem. 1989 Jul;32(7):1571-6.
The synthesis of aspartic proteinase inhibitors derived from a new histidine side-chain analogue of statine (Sta), (3S,4S)-4-amino-3-hydroxy-5-(imidazol-4-yl)pentanoic acid (HiSta, 20), is reported. Boc-HiSta(BOM)-OMe (7) was prepared in 16% overall yield from Boc-His(pi-BOM)-OH via formation of the tetramic acid derivative 11 and stereoselective cis reduction with NaBH4 to the 4-hydroxy lactam 12. Removal of the Boc group from ester 7 (enantiomeric purity ee = 88-90%) and coupling to the tripeptide segment Iva-Val-Val-OH (13) by the DCC/HOBt preactivation method followed by hydrogenolytic removal of the pi-BOM group over Pd(OH)2 on carbon gave Iva-Val-Val-HiSta-OMe (16). This new peptide 16 is a very potent inhibitor of the fungal aspartic proteinase penicillopepsin (Ki = 4.5 x 10(-9) M) that is 10 times more active than the comparable Sta-containing inhibitor 3 and 2-3 times more potent than the new (3S,4S)-4-amino-3-hydroxy-5-phenylpentanoic acid (AHPPA) analogue 17 (Ki = 1.5 x 10(-8) M). However, compound 16, which has an imidazole residue at the P1 position, is a significantly weaker inhibitor of the enzyme than the corresponding analogues with the lysine (5) and ornithine (6) side chains at P1. Considerations that led to the synthesis of 16 and the results of the enzyme kinetics are discussed in detail.